Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients. [Phase 1]
Phase 1 trial assessing the safety and tolerability of AZD8931 alone or with paclitaxel in Japanese patients with breast cancer and other me…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic Evaluation [NA]
This clinical trial compared MRI and Molecular Breast Imaging for breast diagnostic evaluation. The study is completed and results were post…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Cancer [NA]
This clinical trial update reports a completed study of a biological therapy in patients with advanced cancer, including breast, gastric, an…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [NA]
Tamoxifen was studied in a completed clinical trial to prevent breast cancer in survivors of Hodgkin's disease. The study was sponsored by D…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer [Phase 1]
Phase 1 trial evaluating the safety of weekly paclitaxel in combination with neratinib and trastuzumab in metastatic HER2-positive breast ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial [Phase 3]
A Phase 3 trial evaluating simultaneous gemcitabine-docetaxel adjuvant therapy with extended bisphosphonate and surveillance for breast canc…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy [Phase 4]
Phase 4 trial assessing the effect of a bisphosphonate on bone loss in postmenopausal women with breast cancer initiating aromatase inhibito…
-
CLINICAL_TRIALS research · 2014-07-03Clinical Trial Update: Diagnosis and Management of Myofascial Pain Syndrome in Women With Mastectomies [NA]
A clinical trial update from the University of Sao Paulo examining diagnosis and management of myofascial pain syndrome in women who have un…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Effect of Metformin on Breast Cancer Metabolism [Phase 2]
A Phase 2 clinical trial investigating metformin's effect on breast cancer metabolism has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
A completed Phase 1 trial evaluating the safety and dosing of the lapatinib and paclitaxel combination in patients with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 [Phase 1]
A Phase 1 study evaluating lapatinib for advanced or metastatic HER2-overexpressing breast cancer has been completed. The trial was sponsore…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Evaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast Cancer [EARLY_Phase 1]
This early-phase 1 trial evaluated whether AZD6244 (selumetinib) can increase estrogen receptor expression and enhance anti-estrogen respons…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine [Phase 2]
An open-label, randomized Phase II study evaluating Indisulam in combination with capecitabine for metastatic breast cancer was terminated.
-
CLINICAL_TRIALS research · 2014-07-01Clinical Trial Update: Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery [NA]
This clinical trial update describes a study evaluating perioperative administration of COX-2 inhibitors and beta blockers in women with pri…
-
FDA approval · 2014-06-30FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech, Inc. The action updates the product's labeli…
-
FDA approval · 2014-06-30FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approves a supplemental application for Faslodex (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP. The action updates the drug’…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery [NA]
Clinical trial update for MarginProbe, a device used to assess margins during breast-conserving surgery; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) with taxane-based chemotherapy as first-line treatment for HER2-negative breast cancer; resul…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab emtansine (T-DM1) sequenced with anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy fo…
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy [Phase 3]
Phase 3 clinical trial comparing intensity-modulated radiotherapy with 3D-conformal accelerated partial breast irradiation for early-stage b…
-
CLINICAL_TRIALS research · 2014-06-26Clinical Trial Update: Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
Pilot clinical trial update on tamoxifen therapy for patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease [Phase 2]
Update on a Phase 2 trial of BAY88-8223 (Alpharadin) in breast cancer patients with bone-dominant disease; the study has completed.
-
CLINICAL_TRIALS research · 2014-06-25Clinical Trial Update: Study of Arimidex and Radiotherapy Sequencing [Phase 3]
This entry reports an ongoing Phase 3 clinical trial evaluating sequencing of Arimidex (anastrozole) with radiotherapy for breast cancer; no…
-
CLINICAL_TRIALS research · 2014-06-24Clinical Trial Update: Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating liposomal daunorubicin for metastatic breast cancer. The document provides trial information with an unknown status…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating sentinel node biopsy and axillary sampling in operable breast cancer has been terminated.